Ernexa Therapeutics Inc. (ERNA) stock
ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$1.63−0.06 (-3.55%)
Close on Nov 17, 2026Market cap $2.66MP/E –Yield –
Ernexa Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Ernexa Therapeutics's price to sales ratio was 456.9× on Apr 30, 2025, against 176.1× a year earlier. Over the last 4 years it ranged from 28.7× to 456.9×, with a median of 74.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Apr 30, 2025 | 456.9× | +423.3 |
| 2019 | Oct 31, 2019 | 33.6× | −24.4 |
| 2018 | Jan 31, 2018 | 58.1× | +14.6 |
| 2017 | Dec 29, 2017 | 43.4× | −132.7 |
| 2014 | Jan 31, 2014 | 176.1× | +0.0 |
| 2013 | Dec 31, 2013 | 176.1× | +120.7 |
| 2012 | Dec 31, 2012 | 55.4× | −1.4 |
| 2011 | Dec 30, 2011 | 56.8× | – |
See a number that looks wrong?